Our patented technology, Novobrace, is a chemically made internal brace formed by injection of a crosslinking agent directly into the tendon or ligament, immediately adding mechanical support to the injury. This newly formed, flexible brace prevents further propagation of the lesion, provides better stronger healing, and results in the horse returning to full work significantly faster. Crosslinking therapy has also been shown to increase nutritional support to avascular tissues (like tendons); improving nutritional status facilitates the natural healing process. Novobrace may be used as a standalone therapy and also as an adjunct therapy with other tissue healing therapies including stem cells and growth factors. Unlike many other treatments commonly used by veterinarians to treat such injuries, Novobrace does not depend on a biological response or the animal’s immune system for efficacy and can dramatically reduce recovery time for the horse.